| Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates A Ajkunic, E Sayar, MP Roudier, RA Patel, IM Coleman, N De Sarkar, ... npj Precision Oncology 8 (1), 104, 2024 | | 2024 |
| PD09-09 ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY B Shinder, N Mao, Z Zhang, CL Sawyers, BS Carver Journal of Urology 211 (5S), e182, 2024 | | 2024 |
| Diarylhydantoin compounds CL Sawyers, M Jung, CD Chen, S Ouk, D Welsbie, C Tran, J Wongvipat, ... US Patent App. 18/334,355, 2024 | | 2024 |
| Single Cell Analysis of Treatment–Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies S Zaidi, J Park, JM Chan, MP Roudier, JL Zhao, A Gopalan, KM Wadosky, ... bioRxiv, 2024 | | 2024 |
| The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 R Romero, T Chu, TJ González-Robles, P Smith, Y Xie, H Kaur, S Yoder, ... bioRxiv, 2024 | | 2024 |
| The histone methyltransferase KMT2D mediates subtype-specific transcriptional regulation and therapeutic response in prostate cancer S Kittane, E Ladewig, T Li, J Love, A Arruabarrena-Aristorena, X Guo, ... Cancer Research 84 (6_Supplement), 1245-1245, 2024 | | 2024 |
| CDC7 inhibition prevents neuroendocrine transformation in the lung and prostate through MYC degradation A Quintanal-Villalonga, F Uddin, K Kawasaki, E Redin, V Durani, A Sabet, ... Cancer Research 84 (6_Supplement), 2004-2004, 2024 | | 2024 |
| Erg-driven prostate cancer emerges from a basal subset of cells with luminal transcriptomic features E Ladewig, W Feng, C Leslie, C Sawyers Cancer Research 84 (6_Supplement), 1246-1246, 2024 | | 2024 |
| ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY B Shinder, N Mao, N Salsabeel, Z Zhang, CL Sawyers, BS Carver Urologic Oncology: Seminars and Original Investigations 42, S86-S87, 2024 | | 2024 |
| Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European … U Ringborg, J von Braun, J Celis, M Baumann, A Berns, A Eggermont, ... Molecular Oncology 18 (2), 245, 2024 | 3 | 2024 |
| Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer E Lee, Z Zhang, CC Chen, D Choi, ACA Rivera, E Linton, Y Ho, J Love, ... bioRxiv, 2024.03. 18.585532, 2024 | | 2024 |
| Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates A Ajkunic, E Sayar, MP Roudier, RA Patel, IM Coleman, N De Sarkar, ... Research Square, 2023 | 1 | 2023 |
| OA19. 03 Exportin 1 Inhibition Constraints Lineage Plasticity and Histological Transformation through Downregulation of SOX2 A Quintanal-Villalonga, V Durani, A Sabet, E Redin, K Kawasaki, ... Journal of Thoracic Oncology 18 (11), S87-S88, 2023 | | 2023 |
| Substituted diazaspiroalkanes as androgen receptor modulators ME Jung, CL Sawyers, S Ouk, C Tran, J Wongvipat US Patent 11,771,687, 2023 | | 2023 |
| 2233MO CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate Á Quintanal-Villalonga, S Zaidi, WR Karthaus, YA Zhan, M Shafer, J Qiu, ... Annals of Oncology 34, S1150, 2023 | | 2023 |
| Modulator receptorów androgenowych do leczenia raka prostaty i chorób powiązanych z receptorami androgenowymi ME Jung, CL Sawyers, S Ouk, C Tran, J Wongvipat | | 2023 |
| Androgeenireseptorin modulaattori eturauhassyövän ja androgeenireseptoriin liittyvien sairauksien hoitamiseksi M Jung, C Sawyers, S Ouk, C Tran, J Wongvipat | | 2023 |
| Addressing racial and ethnic disparities in AACR project GENIE SM Sweeney, JA Lavery, HE Fuchs, JA Lee, S Brown, KS Panageas, ... NPJ Precision Oncology 7 (1), 81, 2023 | 1 | 2023 |
| Modulators of resistant androgen receptor MD Balbas, MJ Evans, CL Sawyers, Y Shen, D Hosfield, GL Greene US Patent 11,739,069, 2023 | | 2023 |
| Androgen receptormodulator til behandling af prostatacancer og androgen receptor-associerede sygdomme ME Jung, CL Sawyers, S Ouk, C Tran, J Wongvipat | | 2023 |
